FDA approves new treatment to slow progression of early Alzheimer's 02:45. The Food and Drug Administration approved a new Alzheimer's treatment called donanemab on Tuesday, clearing the way for ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

从厨房到实验室，迷迭香可能不仅仅是料理中的调味料，更可能成为对抗老年痴呆的天然武器。随着进一步研究推进，我们有望看到这种植物在未来阿尔兹海默症治疗中扮演越来越重要的角色。

The newly approved drug, Leqembi, should be used only for patients in early and mild stages of Alzheimer’s disease, matching the status of patients in its clinical trials, the F.D.A. label says.

The benefits of the new Alzheimer’s drug lecanemab are too small to justify the costs, NICE said in draft guidance published today. Lecanemab (also called Leqembi and made by Eisai) is for slowing ...

June is Brain and Alzheimer’s Awareness Month — a chance to examine real-world data that links new treatments to changing ...

Kevin Smith, a resident of Clifton Park, is experiencing the benefits of a recently approved Alzheimer's drug, Leqembi, as he ...

A new Alzheimer’s therapy has shown potential in the first human trials. Researchers at the West Virginia University Rockefeller Neuroscience Institute (RNI) found that by pairing focused ...

A surprising discovery about how brain cells handle sugar could shift how scientists approach dementia and Alzheimer’s ...

Breast cancer treatment might offer protection against Alzheimer's disease, with a study of 70,000 survivors showing lower ...

Aging . New Test Shows 90% Accuracy in Diagnosing Early-Stage Dementia . Imagine a simple blood test that could reveal if you're at risk for Alzheimer's disease, years before symptoms become severe.

A new generation of blood tests could accelerate Alzheimer's diagnosis and improve treatment for millions of older Americans. Hotspots ranked Start the day smarter ☀️ Funniest cap messages Get ...